Medicare Enrolled
Dr. Arvind Chaudhry, MD
Optician · Spokane, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chaudhry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chaudhry?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chaudhry
Dr. Arvind Chaudhry is an optician specialist in Spokane, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chaudhry performed 118,871 Medicare services across 5,488 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chaudhry received a total of $92,333 from 117 pharmaceutical and/or device companies across 1734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chaudhry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in WA
$92,333 industry payments
Medicare Practice Summary
Medicare Utilization ↗118,871
Medicare services
Top 1% in WA for optician
5,488
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,944 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 44,000 | $42 | $157 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
16,022 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 15,210 | $1 | $6 |
| Denosumab injection (Prolia/Xgeva) | 14,700 | $19 | $64 |
| Injection, docetaxel, 1 mg | 5,226 | $1 | $7 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,784 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,790 | $1 | $41 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,525 | $8 | $29 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,450 | $66 | $277 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,277 | $8 | $9 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,525 | $10 | $39 |
| Anti-nausea injection (ondansetron/Zofran) | 944 | $0 | $3 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
772 | $103 | $421 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
736 | $12 | $66 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 521 | $3 | $42 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
464 | $2 | $39 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
441 | $70 | $210 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
410 | $96 | $390 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
396 | $78 | $455 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
353 | $11 | $67 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
296 | $23 | $103 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 198 | $133 | $603 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
164 | $7 | $21 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
164 | $16 | $62 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
152 | $55 | $398 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
147 | $196 | $782 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
144 | $51 | $205 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
140 | $6 | $19 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
117 | $1 | $4 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
112 | $57 | $214 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
106 | $1,275 | $4,774 |
| New patient office visit, complex (60-74 min) | 104 | $166 | $673 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
95 | $47 | $180 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 95 | $276 | $1,533 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
91 | $25 | $135 |
| PSA test (prostate cancer screening) | 87 | $18 | $56 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
81 | $49 | $208 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
77 | $6 | $126 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
73 | $23 | $164 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
70 | $16 | $49 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $122 | $509 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
63 | $43 | $177 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
58 | $19 | $83 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
57 | $58 | $234 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
56 | $3 | $11 |
| Gallium Ga-68 gozetotide diagnostic injection A diagnostic injection of Gallium Ga-68 gozetotide used for imaging purposes. |
55 | $723 | $2,736 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
53 | $16 | $65 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
51 | $19 | $70 |
| Iron level test | 49 | $6 | $20 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
49 | $2 | $9 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
44 | $13 | $41 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
38 | $12 | $39 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
37 | $44 | $295 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
32 | $14 | $59 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
31 | $5 | $15 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
26 | $26 | $105 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
24 | $93 | $366 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
13 | $31 | $56 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
12 | $1 | $17 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
89.3% medium
9.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$92,333
Total received (2018-2024)
Avg $13,190/year across 7 years
Top 5% in WA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
117
Companies
1,734
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$45,641 (49.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$37,187 (40.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,506 (10.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,100
2023
$7,723
2022
$10,269
2021
$5,125
2020
$7,010
2019
$24,513
2018
$32,593
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$469
Janssen Biotech, Inc.
$384
Novartis Pharmaceuticals Corporation
$347
Genentech USA, Inc.
$326
AstraZeneca Pharmaceuticals LP
$263
EMD Serono, Inc.
$252
E.R. Squibb & Sons, L.L.C.
$211
Exelixis Inc.
$209
ABBVIE INC.
$178
Incyte Corporation
$169
Astellas Pharma US Inc
$168
GENZYME CORPORATION
$158
Merck Sharp & Dohme LLC
$155
Eisai Inc.
$153
Lilly USA, LLC
$144
Regeneron Healthcare Solutions, Inc.
$138
SOBI, INC
$98
ARRAY BIOPHARMA INC
$96
Bayer Healthcare Pharmaceuticals Inc.
$84
Acrotech Biopharma Inc.
$79
SpringWorks Therapeutics, Inc.
$77
Celgene Corporation
$74
Alnylam Pharmaceuticals Inc.
$71
GlaxoSmithKline, LLC.
$67
Takeda Pharmaceuticals U.S.A., Inc.
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$60
Telix Pharmaceuticals
$58
Rigel Pharmaceuticals, Inc.
$55
Gilead Sciences, Inc.
$53
Blueprint Medicines Corporation
$49
Mirati Therapeutics, Inc.
$43
BeiGene USA, Inc.
$32
ACCORD HEALTHCARE, INC.
$31
TerSera Therapeutics LLC
$30
Daiichi Sankyo Inc.
$29
PROGENICS PHARMACEUTICALS, INC.
$28
Tempus AI, Inc
$25
Stemline Therapeutics Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$22
Spectrum Pharmaceuticals Inc.
$21
Sumitomo Pharma America, Inc.
$20
Fennec Pharmaceuticals, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$18
Myriad Genetic Laboratories, Inc.
$16
Octapharma USA, Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$15
Top 3 companies account for 23.5% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$36,688
Exelixis Inc.
$8,741
AstraZeneca Pharmaceuticals LP
$5,799
Janssen Biotech, Inc.
$5,053
Genentech USA, Inc.
$3,469
Bayer Healthcare Pharmaceuticals Inc.
$3,115
Astellas Pharma US Inc
$2,259
Pharmacyclics LLC, An AbbVie Company
$2,051
Novartis Pharmaceuticals Corporation
$1,839
PFIZER INC.
$1,709
E.R. Squibb & Sons, L.L.C.
$1,508
Amgen Inc.
$1,442
Celgene Corporation
$1,175
GENZYME CORPORATION
$911
Siemens Medical Solutions USA, Inc.
$865
Lilly USA, LLC
$842
Eisai Inc.
$731
Incyte Corporation
$718
Takeda Pharmaceuticals U.S.A., Inc.
$658
Seagen Inc.
$610
Boehringer Ingelheim Pharmaceuticals, Inc.
$579
Merck Sharp & Dohme Corporation
$575
SANOFI-AVENTIS U.S. LLC
$490
EMD Serono, Inc.
$440
Regeneron Healthcare Solutions, Inc.
$434
Merck Sharp & Dohme LLC
$431
AbbVie Inc.
$335
Spectrum Pharmaceuticals Inc.
$324
SOBI, INC
$313
ABBVIE INC.
$312
Rigel Pharmaceuticals, Inc.
$310
Aurobindo Pharma USA, Inc.
$264
Taiho Oncology, Inc.
$258
Blueprint Medicines Corporation
$248
Seattle Genetics, Inc.
$242
Foundation Medicine, Inc.
$236
Agios Pharmaceuticals, Inc.
$220
EISAI INC.
$217
ARRAY BIOPHARMA INC
$210
GlaxoSmithKline, LLC.
$208
TerSera Therapeutics LLC
$204
Gilead Sciences, Inc.
$201
JAZZ PHARMACEUTICALS INC.
$185
AVEO Pharmaceuticals, Inc.
$175
Ipsen Biopharmaceuticals, Inc
$168
Daiichi Sankyo Inc.
$168
Alnylam Pharmaceuticals Inc.
$158
BeiGene USA, Inc.
$147
Kite Pharma, Inc.
$128
Heron Therapeutics, Inc.
$123
PharmaEssentia USA Corporation
$123
Helsinn Therapeutics (U.S.), Inc.
$121
AbbVie, Inc.
$119
Immunomedics, Inc.
$119
Myriad Genetic Laboratories, Inc.
$119
TESARO, Inc.
$108
Jazz Pharmaceuticals Inc.
$107
Dova Pharmaceuticals
$105
Karyopharm Therapeutics Inc.
$101
Acceleron Pharma, Inc.
$100
EUSA Pharma (US) LLC
$100
Pharmacyclics LLC, an AbbVie Company
$100
Acrotech Biopharma Inc.
$100
Janssen Pharmaceuticals, Inc
$99
Acrotech Biopharma LLC
$97
Deciphera Pharmaceuticals Inc.
$96
Epizyme, Inc.,
$92
PUMA BIOTECHNOLOGY, INC.
$87
Mirati Therapeutics, Inc.
$84
MorphoSys, US Inc.
$79
Telix Pharmaceuticals
$78
US Oncology Corporate, Inc.
$77
SpringWorks Therapeutics, Inc.
$77
Sirtex Medical Inc
$74
Dendreon Pharmaceuticals LLC
$71
SERVIER PHARMACEUTICALS LLC
$63
G1 Therapeutics, Inc.
$61
Sumitomo Pharma America, Inc.
$60
Myovant Sciences Inc.
$56
CTI BioPharma Corp.
$56
Lexicon Pharmaceuticals, Inc.
$54
Puma Biotechnology, Inc.
$53
Array BioPharma Inc.
$51
AMAG Pharmaceuticals, Inc.
$50
Secura Bio, Inc.
$48
Pharmacosmos Therapeutics Inc.
$46
Sun Pharmaceutical Industries Inc.
$45
Adaptive Biotechnologies Corporation
$44
Octapharma USA, Inc.
$41
ASD Specialty Healthcare, LLC
$39
Alexion Pharmaceuticals, Inc.
$39
TG THERAPEUTICS, INC.
$38
Janssen Scientific Affairs, LLC
$38
Kyowa Kirin, Inc.
$33
Shire North American Group Inc
$33
Clovis Oncology, Inc.
$32
ACCORD HEALTHCARE, INC.
$31
Verastem, Inc.
$30
Coherus Biosciences Inc.
$30
BTG International, Inc.
$29
PROGENICS PHARMACEUTICALS, INC.
$28
Tempus AI, Inc
$25
Stemline Therapeutics Inc.
$25
INSYS Therapeutics Inc
$22
Servier Pharmaceuticals LLC
$22
Roche Diagnostics Corporation
$20
Sobi, Inc
$20
Mylan Pharmaceuticals Inc.
$20
Fennec Pharmaceuticals, Inc.
$19
ADC Therapeutics America, Inc.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$18
RECORDATI_RARE_DISEASES_INC.
$17
BTG INTERNATIONAL, INC.
$16
Otsuka America Pharmaceutical, Inc.
$14
Aveo Pharmaceuticals, Inc.
$12
Bio Products Laboratory USA, Inc.
$12
Merit Medical Systems Inc
$6
Top 3 companies account for 55.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRACAnalysis CDx · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CINVANTI · COSELA · CRESEMBA · CYRAMZA · Cabometyx · Copiktra · Cresemba · DARZALEX · DIS navify software · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FARYDAK · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · Folotyn · Fulphila · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Gamifant · Gammaplex · Gazyva · Halaven · Herceptin · IBRANCE · IDHIFA · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Idhifa · Imbruvica · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYRISK · Marqibo · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OCTAGAM · OGSIVEO · OJJAARA · ONCASPAR · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · OXLUMO · Orserdu · PADCEV · PANHEMATIN · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PREVYMIS · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · REZUROCK · ROLVEDON · RYBREVANT · RYDAPT · RYZNEUTA · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUBSYS · SUSTOL · SUTENT · StabiliT System · Stivarga · Sustol · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · Udenyca · Ultomiris · VALCHLOR · VELCADE · VENCLEXTA · VERZENIO · VONJO · VORAXAZE · VOTRIENT · VPRIV · VYXEOS · Venclexta · Vitrakvi · Vonjo · Voraxaze · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · Zevalin · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (49%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for optician in WA.
Geographic Context
Opticians within 10 mi
190
Per 100K population
34.9
County median income
$73,513
Nearest hospital
PROVIDENCE HOLY FAMILY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chaudhry is a mixed practice specialist, with above-average Medicare volume (top 1% in WA), with speaking/promotional industry engagement in the top 5% of WA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chaudhry experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Chaudhry performed 44,000 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chaudhry receive payments from pharmaceutical companies?
Yes. Dr. Chaudhry received a total of $92,333 from 117 companies across 1,734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chaudhry's costs compare to other opticians in Spokane?
Dr. Chaudhry's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chaudhry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Spokane
Browse opticians in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Opticians in WA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in WA
Which WA opticians receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology